GLF
PROK icon

Groupe la Francaise’s ProKidney PROK Stock Holding History

Groupe la Francaise’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,500
Closed -$3.17K – 699
2025
Q3 		$3.17K Buy
+1,500
New +$3.99K ﹤0.01% 681

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

Groupe la Francaise's PROK Position: Q4 2025 in Review

Groupe la Francaise sold out of ProKidney (PROK) in Q4 2025, closing a stake of 1,500 shares — an estimated $3.17K sold.

Groupe la Francaise first reported a position in PROK in Q3 2025 and held it in 1 quarter. The position peaked at $3.17K in Q3 2025. 63 funds tracked by Wall St. Rank hold PROK as of Q4 2025.

  • Groupe la Francaise reported no remaining ProKidney position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 1,500 ProKidney shares in Q4 2025, an estimated $3.17K.
  • Groupe la Francaise first reported a position in ProKidney in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's ProKidney position peaked at $3.17K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held ProKidney as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.